The UK's energy partner.

Learn more at equinore.

Good morning from the newsroom of the Financial Times.

Today is Tuesday, November 12th, and this is your FT news briefing.

U.S. private equity firm, Cerberus, is pushing for

big changes at Deutsche Bank. We Work has talked to a high-profile candidate as part of its

search for a new chief executive and a bio proposal on the table for

Walgreens could break a private equity deal record.

Plus I check in with the FT's Georgia. could break a private equity deal record.

Plus I check in with the F.T.'s George Parker about the run-up to the UK's general election.

I'm Mark Filipino, and here's the news you need to start your day.

U.S. Private Equity Group Cerberus wants Deutsche Bank to show Paul Acklietner the door.

Sources tell the F.T. that the German bank's third largest shareholder has lost faith in Deutche's chairman and is pushing for him to be replaced.

These sources say that the U.S. Private Equity Group started to question his role back in April after Deutsche aborted its merger talks with German rival Commerce Bank and Mr. Acklighter endorsed shutting down the talks.

Along with being autia shareholder,

Surberus is the second largest shareholder in Commerce Bank.

But Seberus isn't the only one frustrated with Mr. Acklietner.

Deutia's other big shareholders have expressed an increasingly negative

view of Mr. Accolitner's performance and informal talks they've held. Those shareholders

include members of the Katari Royal Family, funds managed by former

J.P. Morgan Chase Executive Doug Bronstein and asset manager Black Rock.

Walgreens Boots Alliance is contemplating what would be the biggest private equity takeover ever.

...